Cytomedix is a biotech company focused on developing and licensing regenerative biological therapies to primarily address the areas of wound care, infection control, and orthopedic surgery in the United States. CMXI markets the AutoloGel™ System for use on a variety of exuding wounds and the Angel® Concentrated Platelet Rich Plasma System, a blood processing device and disposable products used for the separation of whole blood or a mixture of blood and bone marrow, into red cells, platelet poor plasma (PPP), and PRP in surgical settings. For more information, visit the company’s Web site at: www.cytomedix.com

Noble Financial Capital Markets, an equity research driven, full-service, investment banking boutique, is hosting its ninth annual equity conference at The Hard Rock Hotel in Ft. Lauderdale, FL. Attended by institutional investors from across North America, the event features 135 public company executive teams with an emphasis on healthcare, technology, defense, and new-media / entertainment sectors.

Let us hear your thoughts below: